Algorithm for codevelopment of new drug-predictive biomarker combinations

Accounting for inter- and intrapatient tumor heterogeneity

David R Gandara, Tianhong Li, Primo N Lara, Philip Mack, Karen Kelly, Suzanne Miyamoto, Neal Goodwin, Laurel A Beckett, Mary W. Redman

Research output: Contribution to journal › Article

21 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)321-325
Number of pages5
JournalClinical Lung Cancer
Volume13
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Neoplastic Gene Expression Regulation
Precision Medicine
Tumor Biomarkers
Antineoplastic Agents
Biomarkers
Pharmaceutical Preparations
Neoplasms

Keywords

  • Codevelopment
  • Heterogeneity
  • Personalized therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Algorithm for codevelopment of new drug-predictive biomarker combinations : Accounting for inter- and intrapatient tumor heterogeneity. / Gandara, David R; Li, Tianhong; Lara, Primo N; Mack, Philip; Kelly, Karen; Miyamoto, Suzanne; Goodwin, Neal; Beckett, Laurel A; Redman, Mary W.

In: Clinical Lung Cancer, Vol. 13, No. 5, 09.2012, p. 321-325.

Research output: Contribution to journal › Article

Gandara, DR, Li, T, Lara, PN, Mack, P, Kelly, K, Miyamoto, S, Goodwin, N, Beckett, LA & Redman, MW 2012, 'Algorithm for codevelopment of new drug-predictive biomarker combinations: Accounting for inter- and intrapatient tumor heterogeneity', Clinical Lung Cancer, vol. 13, no. 5, pp. 321-325. https://doi.org/10.1016/j.cllc.2012.05.004
Gandara DR, Li T, Lara PN, Mack P, Kelly K, Miyamoto S et al. Algorithm for codevelopment of new drug-predictive biomarker combinations: Accounting for inter- and intrapatient tumor heterogeneity. Clinical Lung Cancer. 2012 Sep;13(5):321-325. https://doi.org/10.1016/j.cllc.2012.05.004
Gandara, David R ; Li, Tianhong ; Lara, Primo N ; Mack, Philip ; Kelly, Karen ; Miyamoto, Suzanne ; Goodwin, Neal ; Beckett, Laurel A ; Redman, Mary W. / Algorithm for codevelopment of new drug-predictive biomarker combinations : Accounting for inter- and intrapatient tumor heterogeneity. In: Clinical Lung Cancer. 2012 ; Vol. 13, No. 5. pp. 321-325.
@article{2a138a0b78d343ac9065cccc620e7d3c,
title = "Algorithm for codevelopment of new drug-predictive biomarker combinations: Accounting for inter- and intrapatient tumor heterogeneity",
keywords = "Codevelopment, Heterogeneity, Personalized therapy",
author = "Gandara, {David R} and Tianhong Li and Lara, {Primo N} and Philip Mack and Karen Kelly and Suzanne Miyamoto and Neal Goodwin and Beckett, {Laurel A} and Redman, {Mary W.}",
year = "2012",
month = "9",
doi = "10.1016/j.cllc.2012.05.004",
language = "English (US)",
volume = "13",
pages = "321--325",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Algorithm for codevelopment of new drug-predictive biomarker combinations

T2 - Accounting for inter- and intrapatient tumor heterogeneity

AU - Gandara, David R

AU - Li, Tianhong

AU - Lara, Primo N

AU - Mack, Philip

AU - Kelly, Karen

AU - Miyamoto, Suzanne

AU - Goodwin, Neal

AU - Beckett, Laurel A

AU - Redman, Mary W.

PY - 2012/9

Y1 - 2012/9

KW - Codevelopment

KW - Heterogeneity

KW - Personalized therapy

UR - http://www.scopus.com/inward/record.url?scp=84865456673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865456673&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2012.05.004

DO - 10.1016/j.cllc.2012.05.004

M3 - Article

VL - 13

SP - 321

EP - 325

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 5

ER -

Access to Document